Clinical Trial Update: Metformin in Patients With Ulcerative Colitis Treated With Mesalamine [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating metformin in patients with ulcerative colitis who are treated with mesalamine has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Mesalamine (Mesalamine)
• metformin (metformin)

Snippet

Sponsor: Tanta University | Conditions: Inflammatory Bowel Diseases | Phase 2 | Status: COMPLETED